Discover how advances in immunology are reshaping the treatment landscape for IgA nephropathy. This symposium explores the critical role of the B-cell pathway in IgAN pathogenesis, highlights recent KDIGO guideline updates, and examines emerging clinical trial evidence for B-cell directed therapies. Join your fellow nephrology professionals to connect cutting-edge science with clinical practice and gain practical insights into the future of targeted care for people living with IgAN.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Commercial Support
-
ReleasedJul 6, 2026
-
Last day to claim creditJul 7, 2027 9 months left
